Company Filing History:
Years Active: 2025
Title: Innovations of Raja Solomon Viswas
Introduction
Raja Solomon Viswas is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in cancer therapy. His work focuses on developing innovative solutions that can improve treatment outcomes for patients.
Latest Patents
Raja Solomon Viswas holds a patent for a polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3). This patent describes heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies useful for cancer therapy. His innovative approach aims to create radionuclide complexes that can enhance the effectiveness of cancer treatments.
Career Highlights
Raja is currently associated with Abdera Therapeutics Inc., where he continues to advance his research and development efforts. His work at the company reflects his commitment to improving therapeutic options for cancer patients. With a focus on cutting-edge technology, he is dedicated to making a positive impact in the medical field.
Collaborations
Raja collaborates with talented professionals in his field, including Michael J Abrams and Emma Jane Cummins. These partnerships enhance the research and development process, fostering innovation and creativity in their projects.
Conclusion
Raja Solomon Viswas is a pioneering inventor whose work in biotechnology is paving the way for advancements in cancer therapy. His contributions, particularly through his patent, demonstrate his dedication to improving patient care and treatment efficacy.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.